Navigation Links
Insmed to Host 2012 First Quarter Earnings Conference Call
Date:4/24/2012

MONMOUTH JUNCTION, N.J., April 24, 2012 /PRNewswire/ -- Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, will host a conference call on Tuesday, May 8th, 2012, at 8:30 AM ET, to discuss its financial results for the first quarter of 2012.  Insmed intends to issue its quarterly financial results press release before the market opens on May 8th.

To participate in the live conference call, please dial 800-901-5213 (U.S. callers) or 617-786-2962 (international), and provide passcode 51732598.  A live webcast of the call will also be available at http://www.media-server.com/m/p/avwy53ma.  Please allow extra time prior to the webcast to register, download and install any necessary audio software.

The webcast will be archived for 30 days, and a telephone replay of the call will be available for seven days, beginning at 10:30 AM ET on May 8th, at 1-888-286-8010 (U.S. callers) or +1-617-801-6888 (international), using passcode 10283919.

About Insmed

Insmed Incorporated is a biopharmaceutical company focused on the development of innovative inhaled pharmaceuticals for the site-specific treatment of serious lung diseases.  Insmed's primary focus is on the development of inhaled antibiotic therapy delivered via proprietary advanced liposomal pulmonary technology in areas of high unmet need.  For more information, please visit http://www.insmed.com.

Forward-Looking Statements

This release contains forward-looking statements which are made pursuant to provisions of Section 21E of the Securities Exchange Act of 1934. Investors are cautioned that such statements in this release, including statements relating to our financial position, results of operations, the status and the results of preclinical studies and clinical trials and preclinical and clinical data described herein, the
'/>"/>

SOURCE Insmed Incorporated
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Insmed to Host Fourth Quarter and 2011 Year-End Earnings Conference Call
2. Insmed to Present at Lazard Capital Markets 8th Annual Healthcare Conference
3. Insmed Incorporated Provides Regulatory Update on ARIKACE® in Non-Tuberculous Mycobacteria Indication
4. Insmed Incorporated Provides Regulatory Update
5. Insmed to Present at Sixth Annual JMP Securities Healthcare Conference
6. Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2011
7. Insmeds ARIKACE® Demonstrates Sustained Benefit Through Six Cycles of Treatment for Cystic Fibrosis Patients With Pseudomonas Lung Infections
8. Insmed Announces First Quarter 2011 Financial Results
9. Insmed to Host 2011 First Quarter Earnings Conference Call
10. Insmed Announces European Medicines Agency Acceptance of Its Pediatric Investigation Plan for ARIKACE™ in the Cystic Fibrosis Pseudomonas Indication
11. One-for-10 Reverse Stock Split of Insmed Common Stock Becomes Effective
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)...  Omeros Corporation (NASDAQ: OMER ) ... (IND) to evaluate OMS824 in Huntington,s disease has ... Administration (FDA). OMS824 selectively inhibits phosphodiesterase 10 (PDE10), ... linked to a wide range of diseases that ... has shown promising results in animal models directly ...
(Date:5/23/2013)... 2013 SynCardia Systems, Inc. ( www.syncardia.com ), ... Canada and CE ( Europe ) approved ... Centre in Scotland , which boasts ... SynCardia temporary Total Artificial Heart powered by the ... Bodyworks Exhibition, one of the most advanced exhibitions of ...
(Date:5/23/2013)... , May 23, 2013  PAREXEL International Corporation (NASDAQ: ... be presenting at the Jefferies Healthcare Conference in New ... President and Chief Financial Officer, will be making a ... p.m. ET on Monday, June 3, 2013. A ... the "Investors" section of PAREXEL,s website at www.PAREXEL.com ...
Breaking Medicine Technology:Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 2Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 3Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 4Glasgow Science Centre Features SynCardia Total Artificial Heart in $3 Million Exhibition 2Glasgow Science Centre Features SynCardia Total Artificial Heart in $3 Million Exhibition 3PAREXEL International To Present At Jefferies Healthcare Conference 2
... Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX ) announced today ... 23rd Annual Growth Stock Conference on Monday, March 14, 2011 ... in Dana Point, California and at the Barclays Capital 2011 ... a.m. ET at the Loews Miami Hotel, Florida. ...
... Inc. (Nasdaq: JAZZ ) today announced financial results for ... Total revenues for the fourth quarter of 2010 were ... 2009.  Full year 2010 revenues were $173.8 million, up 35 percent ... GAAP net income for the fourth quarter of 2010 was $24.5 ...
Cached Medicine Technology:Jazz Pharmaceuticals Announces Fourth Quarter and Full Year 2010 Results 2Jazz Pharmaceuticals Announces Fourth Quarter and Full Year 2010 Results 3Jazz Pharmaceuticals Announces Fourth Quarter and Full Year 2010 Results 4Jazz Pharmaceuticals Announces Fourth Quarter and Full Year 2010 Results 5Jazz Pharmaceuticals Announces Fourth Quarter and Full Year 2010 Results 6Jazz Pharmaceuticals Announces Fourth Quarter and Full Year 2010 Results 7Jazz Pharmaceuticals Announces Fourth Quarter and Full Year 2010 Results 8
(Date:5/23/2013)... 23, 2013 Elegance for a woman takes on ... her taste, her intrigue can often be found in the mystery ... a woman's soul is through her eyes. It is also ... is! That is why the elegance of a woman can be ... Women today, more than any other time, utilize eyewear to not ...
(Date:5/23/2013)... 2013 Aero Fulfillment Services, a national ... NewWave Biosciences to be the sole fulfillment provider for ... , Brad Cole, CEO New Wave Biosciences said, ... their central location, e-commerce experience with both of our ... end-to-end solution that will expand as our distribution grows.” ...
(Date:5/23/2013)... CA (PRWEB) May 23, 2013 Each month ... most innovative and stylish eco-friendly hybrids and electric cars. Nowhere ... in Los Angeles, the symbolic green car capital. Thankfully this ... Car Tour ride and drive back to Dwell on ... event. , During the first two days of Dwell ...
(Date:5/23/2013)... York (PRWEB) May 23, 2013 Maintaining ... today launches its Summer Health Campaign. Kicking off in ... to offering a luxury bed for everyone and to ... overall health and well-being. , May is Better Sleep ... by the Better Sleep Council due to the Centers ...
(Date:5/23/2013)... two-thirds of patients with high-risk neuroblastoma a common tumor ... cured using tumor-killing cancer drugs. A study published by ... Chemistry & Biology reveals a new genomic approach ... by causing cancer cells to differentiate, or convert from ... screening method, the researchers identified a compound that causes ...
Breaking Medicine News(10 mins):Health News:Dolabany Eyewear Adds Feminine Flare to Women's Designer Eyewear with 2013 New Release of Adelina by Best Image Optical, Inc. 2Health News:NewWave Biosciences Chooses Aero Fulfillment for e-Commerce Distribution of New Product to Reduce Inflammation 2Health News:Dwell Media and Green Car Journal Put You in the Driver Seat At Dwell on Design 2013 2Health News:Dwell Media and Green Car Journal Put You in the Driver Seat At Dwell on Design 2013 3Health News:Dwell Media and Green Car Journal Put You in the Driver Seat At Dwell on Design 2013 4Health News:Dwell Media and Green Car Journal Put You in the Driver Seat At Dwell on Design 2013 5Health News:DUXIANA®, Quality Bed Innovator, Celebrates Better Sleep Month and Launches Summer Health Campaign 2Health News:New screening approach uncovers potential alternative drug therapies for neuroblastoma 2
... Jan. 8 A proposal by the State of ... Home has prompted the 125,000-member American Legion Department of ... 2009, in order to organize and coordinate its members, ... provides more than $50,000 in direct and in-kind support ...
... Jan. 8 United Jewish Communities (UJC) and the ... $10 million to address humanitarian and social needs in ... and stand in solidarity with Israelis during the current ... the Gaza Strip. The funds will enhance programs supported ...
... in French . -->, ... McGill University Health Centre (RI MUHC) and the McGill University ... Canadian and Belgian institutions, have discovered DNA variations in a ... was published in the January issue of the journal ...
... Nassau ColiseumNEW YORK, Jan. 8 Stand Up for a ... -- a Valentine,s Day show with Barry Manilow , in ... be held on February 14th, 2009 at Nassau Coliseum, and tickets ... Ticketmaster.com or by calling Stand Up for a Cure at 212 ...
... Many companies are starting out,the new year with ... than,ever will your success be dependent on your ... To excel in 2009 and win customers, hearts ... customer,listening posts, optimizing complaint management, applying savvy market,segmentation, ...
... We hear it everywhere: "What is your carbon footprint?" ... and how can you reduce yours? It isn,t all ... and planning to bring it down.Listen to this report from ... journalists can access video, audio, text, graphics and photos for ...
Cached Medicine News:Health News:UJC and Jewish Federations of North America Commit $10 Million for Needs in Southern Israel 2Health News:McGill researchers discover gene that increases susceptibility to Crohn's disease 2Health News:McGill researchers discover gene that increases susceptibility to Crohn's disease 3Health News:Barry Manilow Brings Valentine's and Music to New York With Concert to Raise Funds for Breast Cancer Research 2Health News:Marketers Share Customer-Centric Strategies for an Uncertain 2009 Economy, Feb 2-4 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: